$CRON

Cronos Group Inc. (CRON) shares declined 2.73% to $3.21 on Thursday, marking the third straight day of losses, while the broader market indices rose slightly.

Trulieve Cannabis (TRLV) and Cronos Group (CRON) have outperformed the S&P 500 in 2026, with both stocks up 27% through Sept. 18. Trulieve reported Q2 revenue of $271M, EBITDA of $98M, and $74M in free cash flow, while Cronos saw Q2 revenue rise 58% to $53M. Both companies face regulatory risks but have shown strong financial performance.

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced its first Investor Day on September 24, 2026, at its Kingsville, Ontario facility. The event will feature presentations from executives, a fireside chat, and a facility tour. The webcast is open for registration and will be archived for 12 months. Cronos focuses on scaling cannabis products and building an international brand portfolio.

Cronos Group (CRON) reported Q2 net revenue of $53.0M, up 58% YoY, and net income of $35.7M, reversing a $38.5M loss from a year earlier. Gross profit rose 96% to $28.5M, and adjusted EBITDA increased 675% to $13.1M. Growth was driven by strong performance in Israel and international markets, but an Israeli investigation into alleged dumping of Canadian cannabis imports poses a risk. The company repurchased 12.3M shares and held $827M in cash and short-term investments.

Cronos Group Inc. (CRON) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On September 8, 2026, Cronos Group Inc. (the “Company”), its indirect wholly owned subsidiary, CGM B.V. (the “Purchaser”), “Ring” International Holding AG (“Ring”), and Landewyck Tobacco S.A. (“Landewyck,” and together with R

Cronos Group (CRON) expanded its Spinach® brand with new gummy and vape flavors. The SOURZ by Spinach® Blue Raspberry Lemonade Fully Blasted gummies, infused with 100% live resin, and two new vape cartridge flavors are now available in Ontario, with national rollout expected later in 2026. According to the company, Spinach® is Canada’s top edible multipack brand as of June 2026.

Cronos Group Inc. (CRON) filed an SEC Form 8-K — Results of Operations and Financial Condition. Cronos Group Reports 2026 Second Quarter Results Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis Delivered record net revenue in Can

Cronos Group Inc. (CRON) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. cron-20260618 false CRONOS GROUP INC. 0001656472 Stayner Canada 001-38403 Ontario 0001656472 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 193

A federal grand jury in California convicted short seller Andrew Left of securities fraud, the U.S. Justice Department said. He was found guilty of one count of participating in a securities fraud scheme and 12 securities fraud counts. Prosecutors said he profited over $20 million from 2018-2023 via trades tied to Citron Research commentary on companies including Tesla and Nvidia. Sentencing is Aug. 31; he faces up to 25 years.

Activist short seller Andrew Left, founder of Citron Research, was convicted in Los Angeles federal court of securities fraud for allegedly manipulating stock prices using his social-media following. A jury found him guilty on 1 scheme count and 12 securities-fraud counts; prosecutors said he profited about $20 million. He plans to appeal and faces sentencing Aug. 31, with up to 25 years on the lead count.